NumerixS Investment Technologies’s Teva Pharmaceuticals TEVA Stock Holding History

NumerixS Investment Technologies’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-29,309	Closed	-$287K	–	1268
2019 Q4	$287K	Buy	+29,309	New	+$262K	0.06%	388
2019 Q1	–	Sell	-33,100	Closed	-$519K	–	1330
2018 Q4	$519K	Sell	33,100 -169,000	-84%	-$3.46M	0.17%	132
2018 Q3	$4.29M	Buy	+202,100	New	+$4.69M	0.81%	6
2017 Q1	–	Sell	-5,200	Closed	-$189K	–	1366
2016 Q4	$189K	Sell	5,200 -151,247	-97%	-$6.04M	0.02%	687
2016 Q3	$7.2M	Buy	156,447 +100,966	+182%	+$5.27M	0.93%	13
2016 Q2	$2.79M	Buy	+55,481	New	+$2.95M	0.39%	36
2015 Q4	–	Sell	-91,997	Closed	-$5.19M	–	873
2015 Q3	$5.19M	Buy	+91,997	New	+$5.96M	0.59%	32
2015 Q1	–	Sell	-4,504	Closed	-$259K	–	682
2014 Q4	$259K	Buy	+4,504	New	+$251K	0.09%	345

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

NumerixS Investment Technologies's TEVA Position: Q1 2020 in Review

NumerixS Investment Technologies sold out of Teva Pharmaceuticals (TEVA) in Q1 2020, closing a stake of 29,309 shares — an estimated $287K sold.

NumerixS Investment Technologies first reported a position in TEVA in Q4 2014 and held it in 8 quarters. The position peaked at $7.2M in Q3 2016. 459 funds tracked by Wall St. Rank hold TEVA as of Q1 2020.

NumerixS Investment Technologies reported no remaining Teva Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
NumerixS Investment Technologies sold 29,309 Teva Pharmaceuticals shares in Q1 2020, an estimated $287K.
NumerixS Investment Technologies first reported a position in Teva Pharmaceuticals in Q4 2014 and held it in 8 quarters.
NumerixS Investment Technologies's Teva Pharmaceuticals position peaked at $7.2M in Q3 2016.
459 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2020.

Based on NumerixS Investment Technologies's 13F filing for Q1 2020, filed 15 May 2020.